CMES3 Hypoparathyroidism: New Treatments and Guidelines

Program: CMES Ancillary Events
Clinical Session
Friday, April 1, 2016: 6:30 PM-9:30 PM
Pacific Ballroom (The Renaissance)
Supported by an educational grant from Shire Pharmaceuticals

Registration is required for this session:

Learning Objectives:

Upon completing this activity, learners will be better able to:

  • Recognize the scope of the disease burden of hypoparathyroidism and its complications
  • Weigh the advantages, limitations, and safety of available treatment options
  • Summarize the evidence and principles of recently published guidelinesĀ 
7:00 PM

John P Bilezikian, MD, Medicine, College of Physicians and Surgeons, Columbia University, New York, NY
Disclosure Not Provided: JPB
7:10 PM

Michael Mannstadt, MD, Endocrine Unit, Massachusetts General Hospital, Boston, MA
Disclosure Not Provided: MM
7:45 PM

Dolores M Shoback, Endocrine Unit, SF-VAMC, University of California San Francisco, San Francisco, CA
Disclosure Not Provided: DMS
8:20 PM

John P Bilezikian, MD, Medicine, College of Physicians and Surgeons, Columbia University, New York, NY
Disclosure Not Provided: JPB
See more of: CMES Ancillary Events